Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
Categories
Web Exclusives
Web Exclusive Articles
Webinars
Search ...
VBCN - May 2015 Volume 2, No 1
Should Neurologists Prescribe Opioids for the Management of Chronic Pain?
By
Chase Doyle
Pain Management
VBCN - May 2015 Volume 2, No 1
At the 2015 AAN meeting, experts discussed the role and responsibility of neurologists who prescribe opioids for chronic pain management in light of growing concerns of opioid misuse and abuse.
Read More
RRMS Treatment Is Cost-Effective After 6 Years
By
Rosemary Frei, MSc
Multiple Sclerosis
VBCN - May 2015 Volume 2, No 1
Patients receiving treatment of relapse-remitting multiple sclerosis (RRMS) progressed significantly slower than predicted, leading investigators to suggest that RRMS treatment is both clinically and cost-effective.
Read More
Teriflunomide Demonstrates Significant Efficacy in Patients with Multiple Sclerosis
By
Chase Doyle
Multiple Sclerosis
VBCN - May 2015 Volume 2, No 1
The results from 3 studies demonstrate the efficacy of teriflunomide on reducing relapses across a range of patients, including those with early and relapsing multiple sclerosis
Read More
Stroke Center Reduces Door-to-Needle Times to Less Than 30 Minutes
By
Corbin Davis
Stroke
VBCN - May 2015 Volume 2, No 1
As one center showed, streamlined coordination among emergency department physicians, pharmacists, and neurologists can improve outcomes of patients diagnosed with stroke.
Read More
High Doses of Biotin Improve Physical, Neurologic Function in Patients with Progressive Multiple Sclerosis
By
Chase Doyle
Multiple Sclerosis
VBCN - May 2015 Volume 2, No 1
Patients with primary and secondary progressive multiple sclerosis (MS) showed improvements in standard measures of physical and neurologic disability after taking high doses of biotin (300 mg daily) for 1 year, according to results of a phase 3 clinical trial presented at the 2015 annual meeting of the American Academy of Neurology.
Read More
Neuropsychological Outcomes After Deep Brain Stimulation for Parkinson Disease
In the Literature
VBCN - May 2015 Volume 2, No 1
An in-depth analysis from the randomized, controlled Netherlands Subthalamic and Pallidal Stimulation (NSTAPS) clinical trial found no substantial differences in neuropsychological outcomes in patients with Parkinson disease who received globus pallidus internus (GPi) deep brain stimulation (DBS) or subthalamic nucleus (STN) DBS.
Read More
Socioeconomic Status Linked to Child’s Brain Size
In the Literature
VBCN - May 2015 Volume 2, No 1
In the largest study of its kind, a team of neuroscientists concluded that socioeconomic adversity affects brain development in children.
Read More
Disturbing Trends in Headache Management
In the Literature
VBCN - May 2015 Volume 2, No 1
The treatment of headache for more than 12 million Americans costs more than $31 billion yearly.
Read More
Epstein-Barr Virus Genetic Variants Associated with Multiple Sclerosis
In the Literature
VBCN - May 2015 Volume 2, No 1
A new study unveils a strong association between Epstein-Barr virus (EBV) genomic variants and multiple sclerosis, reinforcing the idea that EBV contributes to the development of multiple sclerosis.
Read More
Brain’s “Lightning Bolts” Indicate Learning
In the Literature
VBCN - May 2015 Volume 2, No 1
Lightning bolt images in the dendrites of brain cells may reveal how the brain sorts, stores, and interprets information during learning, according to researchers at New York University (NYU) Langone Medical Center.
Read More
Page 1 of 3
1
2
3
Search ...
Home
Issues
Latest Issue
Issue Archive
Special Issues
Categories
Web Exclusives
Web Exclusive Articles
Webinars
Subscribe to
Value-Based Care in Neurology
Stay up to date with personalized medicine by subscribing to receive the free
VBCN
e‑Newsletter.
I'd like to receive:
VBCN
e‑Newsletter
I have reviewed and consent to the terms of
VBCN
's
Privacy Policy
, and
VBCN
has my permission to retain my information in its database, and to forward pertinent communications to me.